Ocular Therapeutix, Inc. (OCUL) Financials

OCUL Assets vs Liabilities

DateAssetsLiabilities
June 30, 2026 671.3 million 151.3 million
March 31, 2026 732.5 million 151.0 million
Dec. 31, 2025 808.1 million 153.7 million
Sept. 30, 2025 410.9 million 152.7 million

OCUL Free Cash Flow and Stock based compensation

Graph available only for paid members. Upgrade to see it.
DateFree Cash FlowStock based compensation
June 30, 2026 -70.6 million 14.6 million
March 31, 2026 -70.7 million 15.6 million
Dec. 31, 2025 -57.1 million 11.4 million
Sept. 30, 2025 -56.7 million 11.7 million

OCUL Net Income

No data available :(

OCUL Cash and Debt

Graph available only for paid members. Upgrade to see it.
DateCashDebtCapital Lease
June 30, 2026 598.6 million 72.8 million 3.5 million
March 31, 2026 666.7 million 72.1 million 4.2 million
Dec. 31, 2025 737.1 million 71.3 million 5.6 million
Sept. 30, 2025 344.8 million 70.6 million 6.4 million

OCUL Shares Outstanding

Graph available only for paid members. Upgrade to see it.
DateShares Outstanding
June 30, 2026 225.0 million
March 31, 2026 224.1 million
Dec. 31, 2025 222.9 million
Sept. 30, 2025 183.9 million

OCUL Expenses

Graph available only for paid members. Upgrade to see it.
DateCapexR&DG&AS&M
June 30, 2026 3.4 million 54.1 million 39.4 million 17.3 million
March 31, 2026 4.7 million 66.2 million 36.6 million 16.6 million
Dec. 31, 2025 2.8 million 50.8 million 30.6 million 13.0 million
Sept. 30, 2025 6.0 million 52.4 million 29.1 million 13.1 million

OCUL Cost of Revenue

Graph available only for paid members. Upgrade to see it.
DateRevenueCost of Revenue
June 30, 2026 13.5 million 2.0 million
March 31, 2026 10.8 million 1.3 million
Dec. 31, 2025 13.3 million 1.6 million
Sept. 30, 2025 14.5 million 1.8 million

OCUL Revenue by Segment

Graph available only for paid members. Upgrade to see it.

OCUL

Price: $10.04

52 week price:
6.23
16.44

Payout Ratio Range:
-158.37%
-1.71%

Earnings Per Share: -1.47 USD

Exchange: NGM

Sector: Healthcare

Industry: Biotechnology

Country: United States

Volume: 567800

Ebitda: -14.6 million

Market Capitalization: 2.2 billion

Links: